Table 4.
p-values of the columns used in the models, based on the chi-square test.
| p-value | Cancer specific | Overall | One-year | Three-year | Five-year |
|---|---|---|---|---|---|
| IDADE | 2.06 e−1 | 0.00 | 0.00 | 0.00 | 0.00 |
| SEXO | 7.10 e−6 | 0.00 | 1.85 e−2 | 3.36 e−9 | 5.77 e−9 |
| IBGE | 4.43 e−2 | 1.61 e−2 | 3.96 e−3 | 9.95 e−1 | 1.00 |
| CATEATEND | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DIAGPREV | 0.00 | 0.00 | 5.36 e−8 | 2.21 e−1 | 0.00 |
| EC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| TRATHOSP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| NENHUM | 1.75 e−3 | 2.86 e−3 | 8.92 e−6 | 7.82 e−9 | 2.41 e−5 |
| CIRURGIA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| RADIO | 0.00 | 0.00 | 0.00 | 0.00 | 2.19 e−1 |
| QUIMIO | 0.00 | 0.00 | 0.00 | 7.84 e−9 | 2.17 e−3 |
| HORMONIO | 8.09 e−1 | 8.64 e−1 | 4.11 e−9 | 7.35 e−10 | 1.77 e−7 |
| TMO | 7.05 e−1 | 6.41 e−1 | 8.29 e−1 | 5.12 e−1 | 2.53 e−1 |
| IMUNO | 7.39 e−1 | 9.60 e−1 | 6.87 e−1 | 1.23 e−1 | 3.21 e−2 |
| OUTROS | 0.00 | 7.38 e−1 | 6.25 e−6 | 0.00 | 0.00 |
| NENHUMANT | 7.48 e−1 | 2.77 e−1 | 9.62 e−1 | 9.53 e−1 | 6.53 e−1 |
| CONSDIAG | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| TRATCONS | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| DIAGTRAT | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| ANODIAG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DRS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| RRAS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| RECNENHUM | 0.00 | 0.00 | 0.00 | 0.00 | 3.45 e−6 |
| IBGEATEN | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| ESCOLARI2 | 0.00 | 0.00 | 0.00 | 3.75 e−1 | 9.94 e−1 |
The independence of the input variables with the output of each of the studies was analyzed using the chi-squared test, and all the shown features were included in the analyses conducted.